Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo

Figure 3

Effect of Rh2 on serum CK, LDH, and AST in DOX-treated animals. Animal serum was prepared, and then the serum CK (a), LDH (b), and AST (c) were detected. 1: Control group; 2: DOX group; 3: DOX plus Rh2 5 mg/kg group; 4: DOX plus Rh2 10 mg/kg group; 5: DOX plus Rh2 20 mg/kg group. All data are expressed as means ± SD (𝑛=10). ^#𝑃<0.01, compared with control group; *𝑃<0.05, compared with DOX group; **𝑃<0.01, compared with DOX group.

(a)

(b)

(c)